|
That statement was related to a report by Institutional Shareholder Services, a proxy advisory firm. Earlier this month, ISS said First Manhattan had chosen good nominees and recommended that Vivus shareholders elect Astrue, Denner, and Norton to the company's board. "The dissidents have made a compelling case that there is a clear need for additional board oversight of the Qsymia launch and commercialization as well as greater shareholder perspective on the board," ISS said in its report. First Manhattan maintained Tuesday that Vivus rescheduled the meeting because it was afraid its own nominees would lose the election. Vivus said it felt it needed to report First Manhattan's statements to the SEC and said it adjourned the shareholder vote so its shareholders would have additional time to consider accurate information. Shares of Vivus rose 9 cents to $14.58 in afternoon trading.
[Associated
Press;
Copyright 2013 The Associated
Press. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.